OSN 001

Drug Profile

OSN 001

Latest Information Update: 01 Jul 1998

Price : $50

At a glance

  • Originator Otsuka Pharmaceutical; Snow Brand Milk Products
  • Class Amino acids; Proteins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Nutrition disorders

Most Recent Events

  • 01 Jul 1998 Launched for Nutritional disorders in Japan (PO)
  • 25 Jul 1995 Phase-III clinical trials for Nutritional disorders in Japan (PO)
  • 02 Feb 1995 No-Development-Reported for Nutritional disorders in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top